Clinical trial
Immunogenicity, Safety, and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults
NCT02233816 is registered in ClinicalTrials.gov with Medicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunogenicity, Safety, and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults
- Lead sponsor
- Medicago
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 28, 2014
- Completion date
- June 22, 2015
- Enrollment
- 300 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.